Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Individuals with a BMI of 30 or higher, or those with a BMI of 2729.9 plus at least one weight-related health condition (such as high blood pressure or type 2 diabetes), may be considered for Eden's semaglutide program
This change is expected to drive prices down, and open up access for millions of people
Maintaining weight loss after stopping treatment One question that too few telehealth providers address upfront is what happens when you stop taking the medication
Employees beyond that cap and OSU Health Plan members effective January 1, 2026 are on cash-pay for weight-loss GLP-1
Tirzepatide outperforms semaglutide for weight loss and blood sugar control in most clinical settings
